13F filerCIK 1536411 ↗
Duquesne Family Office
You are looking at Q4 2018. See the latest, Q3 2026 →
Reported value
$1.73B
−18% on the quarter before
Positions
31
13 new, 22 sold out
Top 10
75.8%
of the value
Est. gain
−$158.8M
on stocks held all quarter
Est. return
−12.8%
on those stocks since Q3 2018
Positions as of Dec 31, 2018, from Duquesne Family Office's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2018. Striped tiles are options.
Largest buys
Since Q3 2018, sized at quarter-end prices.
- Microsoft~$111.0MAdded, 19.2% → 27.2% of the portfolio+1,093,171 shares
- TeslaPUT~$99.8MNew, 0.0% → 5.8% of the portfolio+299,800 underlying
- Ishares Tr~$65.6MNew, 0.0% → 3.8% of the portfolio+1,679,700 shares
- Coupa Software Inc~$62.3MAdded, 0.5% → 4.1% of the portfolio+990,900 shares
- Intuitive Surgical~$52.8MNew, 0.0% → 3.1% of the portfolio+110,300 shares
- Illumina Inc~$41.8MNew, 0.0% → 2.4% of the portfolio+139,500 shares
- Abbott Labs~$40.8MAdded, 2.6% → 5.4% of the portfolio+563,600 shares
- Delta Air Lines Inc Del~$31.3MNew, 0.0% → 1.8% of the portfolio+626,600 shares
- MercadoLibre~$21.7MNew, 0.0% → 1.3% of the portfolio+74,016 shares
- American Airls Group Inc~$16.9MNew, 0.0% → 1.0% of the portfolio+524,900 shares
Largest sells
Since Q3 2018, sized at quarter-end prices.
- Alphabet~$186.2MCut, 10.9% → 0.7% of the portfolio−178,201 shares
- Ishares Tr~$65.8MCut, 6.0% → 2.0% of the portfolio−682,600 shares
- Salesforce~$65.8MCut, 11.7% → 8.5% of the portfolio−480,115 shares
- Citigroup Inc~$47.9MSold out, 2.3% → 0.0% of the portfolio−667,100 shares
- Select Sector SPDR Tr~$39.6MSold out, 1.9% → 0.0% of the portfolio−522,900 shares
- Vaneck Vectors ETF Tr~$39.4MSold out, 1.9% → 0.0% of the portfolio−1,565,100 shares
- Amazon~$29.8MCut, 11.3% → 8.6% of the portfolio−19,867 shares
- Gilead Sciences Inc~$27.6MCut, 5.4% → 3.7% of the portfolio−441,555 shares
- PayPal~$26.8MCut, 3.0% → 2.0% of the portfolio−318,965 shares
- Twenty First Centy Fox Inc~$25.8MSold out, 1.2% → 0.0% of the portfolio−557,800 shares
Holdings
As of Dec 31, 2018; changes in shares since Sep 30, 2018.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +31% · price −11.2% | 27.2% | $469.1M | −$45.1M | ||||||
| AmazonCOM · shares −17% · price −25.0% | 8.6% | $147.8M | −$49.3M | ||||||
| SalesforceCOM · shares −31% · price −13.9% | 8.5% | $146.9M | −$23.7M | ||||||
| TeslaPUTCOM · shares New | 5.8% | $99.8M | — | ||||||
| Abbott LabsCOM · shares +77% · price −1.4% | 5.4% | $93.7M | −$754,196 | ||||||
| WorkdayCL A · shares +17% · price +9.4% | 4.9% | $83.9M | +$6.1M | ||||||
| Coupa Software IncCOM · shares +707% · price −20.5% | 4.1% | $71.1M | −$2.3M | ||||||
| AdobeCOM · shares +13% · price −16.2% | 3.9% | $68.1M | −$11.7M | ||||||
| Ishares TrMSCI EMG MKT ETF · shares New | 3.8% | $65.6M | — | ||||||
| Gilead Sciences IncCOM · shares −30% · price −19.0% | 3.7% | $64.0M | −$15.0M | ||||||
| Intuitive SurgicalCOM NEW · shares New | 3.1% | $52.8M | — | ||||||
| Illumina IncCOM · shares New | 2.4% | $41.8M | — | ||||||
| PayPalCOM · shares −44% · price −4.3% | 2.0% | $34.4M | −$1.5M | ||||||
| Medtronic PlcSHS · shares 0% · price −7.5% | 2.0% | $33.9M | −$2.8M | ||||||
| Ishares TrNASDAQ BIOTECH · shares −66% · price −20.9% | 2.0% | $33.8M | −$8.9M | ||||||
| Delta Air Lines Inc DelCOM NEW · shares New | 1.8% | $31.3M | — | ||||||
| AlibabaSPONSORED ADS · shares +123% · price −16.8% | 1.4% | $23.9M | −$2.2M | ||||||
| Ac Immune SaSHS · shares 0% · price +18.1% | 1.4% | $23.5M | +$3.6M | ||||||
| MercadoLibreCOM · shares New | 1.3% | $21.7M | — | ||||||
| NetflixCOM · shares +1,169% · price −28.4% | 1.0% | $17.7M | −$553,187 | ||||||
| American Airls Group IncCOM · shares New | 0.98% | $16.9M | — | ||||||
| Agilent Technologies IncCOM · shares New | 0.86% | $14.9M | — | ||||||
| ServiceNowCOM · shares −58% · price −9.0% | 0.85% | $14.6M | −$1.4M | ||||||
| Hologic IncCOM · shares New | 0.80% | $13.8M | — | ||||||
| AlphabetCAP STK CL A · shares −94% · price −13.4% | 0.68% | $11.8M | −$1.8M | ||||||
| Total 31 positions | 100% | $1.73B | −$158.8M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2018 to Q4 2018: 18 stocks held throughout, down $158.8M (−12.8%).
- Workday+$6.1M+9%
- Ac Immune Sa+$3.6M+18%
- Adobe−$11.7M−16%
- Gilead Sciences Inc−$15.0M−19%
- Salesforce−$23.7M−14%
- Microsoft−$45.1M−11%
- Amazon−$49.3M−25%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 16, 2026 | $4.47B−14% | SEC ↗ |
| Q2 2026 | Aug 14, 2026 | $5.21B+54% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $3.38B−25% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $4.49B+11% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $4.06B−0% | SEC ↗ |
| Q2 2025 | Aug 15, 2025 | $4.07B+33% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $3.06B−18% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $3.72B+26% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $2.95B+1% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $2.92B−34% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $4.39B+31% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $3.35B+20% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $2.79B−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $2.87B+25% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $2.31B+14% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $2.02B+15% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $1.76B+28% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $1.38B−40% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $2.31B−16% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $2.76B−10% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $3.08B−24% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 (amended) | $4.04B−11% | SEC ↗ |
| Q1 2021 | May 17, 2021 (amended) | $4.53B+22% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $3.71B+8% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $3.44B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $3.27B+32% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $2.47B−28% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $3.41B+33% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $2.57B−24% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $3.37B−2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $3.45B+100% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $1.73B−18% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $2.10B+2% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $2.07B+14% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $1.81B−9% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $1.98B−10% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $2.20B+18% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $1.87B+22% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $1.52B+49% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $1.03B−9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $1.13B+30% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $870.7M−35% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $1.34B | SEC ↗ |